Lundbeck and Otsuka´s brexpiprazole for adult patients with schizophrenia accepted for review by EMA (84KB)
(WorldNews Japan)

For Immediate Release March 24, 2017 Company name Otsuka Holdings Co., Ltd. Representative Tatsuo Higuchi President and Representative Director, CEO Code number 4578 First Section , Tokyo Stock Exchange Inquiries Yuji Kogure Director, Investors Relations Department Lundbeck and Otsuka`s brexpiprazole for adult patients with schizophrenia accepted for review by EMA H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) announce that the European...